Cargando…

New data: new options for front-line therapy in NSCLC?

Detalles Bibliográficos
Autor principal:	Reinmuth, Niels
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922564/ https://www.ncbi.nlm.nih.gov/pubmed/29713500 http://dx.doi.org/10.1136/esmoopen-2018-000369

Ejemplares similares

It’s Got Too Greedy. New Therapeutic Options for Metabolic[ally] Addicted NSCLC?
por: Caiola, Elisa, et al.
Publicado: (2020)

Reports from the front lines: Field Notes, a new JIAS feature
por: Mayer, Kenneth H., et al.
Publicado: (2022)

The Front Line of Genomic Translation
por: O'Neill, Suzanne C., et al.
Publicado: (2012)

Family doctors on the front line
por: Mash, Bob
Publicado: (2020)

Conservation stories from the front lines
por: Gross, Liza, et al.
Publicado: (2018)

Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis
por: Vashisht, Rohit, et al.
Publicado: (2015)

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
por: Passiglia, Francesco, et al.
Publicado: (2021)

Fruit flies on the front line: the translational impact of Drosophila
por: Perrimon, Norbert, et al.
Publicado: (2016)

Care home staff and residents on the pandemic front line
por: The Lancet Healthy Longevity
Publicado: (2020)

Environmental Florence Nightingales: nursing's new front line.
por: Wakefield, J
Publicado: (2001)

Lenvatinib in elderly hepatocellular carcinoma patients, a new therapeutic option in first line
por: Roth, Gael S., et al.
Publicado: (2020)

Palbociclib: A New Option for Front-Line Treatment of Metastatic, Hormone Receptor–Positive, HER2-Negative Breast Cancer
por: Bowles, Harmony J., et al.
Publicado: (2015)

IceLines – A new data set of Antarctic ice shelf front positions
por: Baumhoer, Celia A., et al.
Publicado: (2023)

Life Interrupted: On the Front Lines With COVID-19
por: Argulian, Edgar, et al.
Publicado: (2020)

Nandrolone decanoate: new therapeutic option for telomeropathies?
por: Frieri, Camilla
Publicado: (2023)

Nurses at the Front Line of COVID-19: Roles, Responsibilities, Risks, and Rights
por: Fawaz, Mirna, et al.
Publicado: (2020)

Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation
por: Tian, Tian, et al.
Publicado: (2021)

New treatment options to reduce heart failure hospitalization
por: Papp, Zoltán, et al.
Publicado: (2020)

Endometriosis: An Inflammatory Disease That Requires New Therapeutic Options
por: Donnez, Jacques, et al.
Publicado: (2022)

Overcoming drug resistance in glioblastoma: new options in sight?
por: Kopecka, Joanna, et al.
Publicado: (2021)

What Can We Save for the First-Line Treatment of NSCLC in 2016?
por: Rossi, David
Publicado: (2017)

Controversies in NSCLC: which second-line strategy after chemo-immunotherapy?
por: Moliner, L., et al.
Publicado: (2023)

Outlook into the future of front-line immune checkpoint inhibition in metastatic urothelial carcinoma
por: Brown, Jason R., et al.
Publicado: (2021)

Options for the LEP front end machines
por: Hübner, K
Publicado: (1979)

Green tea: a new option for the prevention or control of osteoarthritis
por: Katiyar, Santosh K, et al.
Publicado: (2011)

Tapentadol: a new option for the treatment of cancer and noncancer pains
por: Dickenson, Anthony H, et al.
Publicado: (2019)

New option for improving hematological recovery: suppression of luteinizing hormone
por: Elias, Harold K., et al.
Publicado: (2020)

Advanced endometrial cancer: New medical treatment options on the horizon
por: Vistad, Ingvild, et al.
Publicado: (2023)

Targeting KRAS in NSCLC: Old Failures and New Options for “Non-G12c” Patients
por: Jacobs, Francesca, et al.
Publicado: (2021)

The Imposing Front
Publicado: (1913)

Texas to the Front
Publicado: (1902)

Long-term survival with anlotinib as a front-line treatment in an elderly NSCLC patient: A case report
por: Wang, Jingyi, et al.
Publicado: (2023)

Notching up a new therapeutic strategy for Non-Small Cell Lung Carcinoma (NSCLC)
por: Maraver, Antonio, et al.
Publicado: (2012)

Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients
por: Reinmuth, Niels, et al.
Publicado: (2013)

Repurposing A549 Adenocarcinoma Cells: New Options for Drug Discovery
por: Garcia-de-Alba, Carolina
Publicado: (2021)

Building options at project front-end strategizing
por: Biesek, Guilherme, et al.
Publicado: (2014)

Chemotherapy and/or immune checkpoint inhibitors in NSCLC first-line setting: what is the best approach?
por: Gravara, Luigi Della, et al.
Publicado: (2020)

Purinergic signaling: A new front-line determinant of resistance and susceptibility in leishmaniasis
por: Chaves, Mariana, et al.
Publicado: (2022)

Tivozanib for hepatocellular carcinoma: not likely a new option
por: Estrade, Florian, et al.
Publicado: (2020)

Nursing during Times of Pandemic: from Courage on the Front Line to Heroic Courage in Banksy's Mural
por: Barría P., R. Mauricio
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1cbpgltihhv5hlekfl8e93neuv